Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Mach

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Przeglad Lekarski|October 19, 2007
[Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]Małgorzata Zwolińska-Wcisło, Tomasz Brzozowski, Alicja Budak, et al.
Folia Medica Cracoviensia|December 5, 2008
[Candidiasis in the experimental model of ulcerative colitis]Małgorzata Zwolińska-Wcisło, Zbigniew Sliwowski, Danuta Drozdowicz, et al.
Antiviral Therapy|January 24, 2012
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotypeMilan J Sonneveld, Vincent Rijckborst, Yilmaz Cakaloglu, et al.
Hepatology International|May 22, 2016
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failureFabien Zoulim, Jolanta Białkowska-Warzecha, Mircea Mihai Diculescu, et al.
The American Journal of Gastroenterology|October 13, 2006
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudineHajo J Flink, Bettina E Hansen, E Jenny Heathcote, et al.
Przeglad Epidemiologiczny|March 7, 2012
[Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)]Rafał Krygier, Robert Flisiak, Viola Bacia, et al.
Gastroenterology|July 1, 2008
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2bErik H C J Buster, Hajo J Flink, Yilmaz Cakaloglu, et al.
Kardiologia Polska|April 30, 2021
Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in PolandMichał Terlecki, Wiktoria Wojciechowska, Marek Klocek, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 3, 2004
[Peginterferon alpha-2b in patients with chronic hepatitis C]Jacek Juszczyk, Jolanta Białkowska, Beata Bolewska, et al.
BMC Medical Genomics|January 7, 2017
A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patientsAgnieszka Paziewska, Andrzej Habior, Agnieszka Rogowska, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Przeglad Lekarski|October 19, 2007
[Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]Małgorzata Zwolińska-Wcisło, Tomasz Brzozowski, Alicja Budak, et al.
Folia Medica Cracoviensia|December 5, 2008
[Candidiasis in the experimental model of ulcerative colitis]Małgorzata Zwolińska-Wcisło, Zbigniew Sliwowski, Danuta Drozdowicz, et al.
Antiviral Therapy|January 24, 2012
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotypeMilan J Sonneveld, Vincent Rijckborst, Yilmaz Cakaloglu, et al.
Hepatology International|May 22, 2016
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failureFabien Zoulim, Jolanta Białkowska-Warzecha, Mircea Mihai Diculescu, et al.
The American Journal of Gastroenterology|October 13, 2006
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudineHajo J Flink, Bettina E Hansen, E Jenny Heathcote, et al.
Przeglad Epidemiologiczny|March 7, 2012
[Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)]Rafał Krygier, Robert Flisiak, Viola Bacia, et al.
Gastroenterology|July 1, 2008
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2bErik H C J Buster, Hajo J Flink, Yilmaz Cakaloglu, et al.
Kardiologia Polska|April 30, 2021
Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in PolandMichał Terlecki, Wiktoria Wojciechowska, Marek Klocek, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 3, 2004
[Peginterferon alpha-2b in patients with chronic hepatitis C]Jacek Juszczyk, Jolanta Białkowska, Beata Bolewska, et al.
BMC Medical Genomics|January 7, 2017
A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patientsAgnieszka Paziewska, Andrzej Habior, Agnieszka Rogowska, et al.
Pageof 13